Login / Signup

Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status.

Matthew M MirskyCarley MitchellAugustine HongShufen CaoPingfu FuSeunghee MargeviciusSulin WuAfshin DowlatiAriel NelsonJ Eva SelfridgeNikhil RamaiyaChristopher J HoimesAsrar AlahmadiDebora S Bruno
Published in: Cancer management and research (2023)
In a large health-care organization, patients treated with checkpoint inhibitors by DOPs benefited from a significant OS advantage that was durable after controlling for racial and socioeconomic factors, providing evidence that disease-oriented care has the potential to mitigate racial and socioeconomic disparities.
Keyphrases